001     163961
005     20240229133511.0
024 7 _ |a 10.1002/ijc.33339
|2 doi
024 7 _ |a pmid:33038275
|2 pmid
024 7 _ |a 0020-7136
|2 ISSN
024 7 _ |a 1097-0215
|2 ISSN
024 7 _ |a altmetric:92156232
|2 altmetric
037 _ _ |a DKFZ-2020-02174
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Christakoudi, Sofia
|0 0000-0001-9219-4436
|b 0
245 _ _ |a Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
260 _ _ |a Bognor Regis
|c 2021
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1614940647_29979
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2021 Apr 1;148(7):1637-1651
520 _ _ |a Obesity is a risk factor for several major cancers. Associations of weight change in middle adulthood with cancer risk, however, are less clear. We examined the association of change in weight and body mass index (BMI) category during middle adulthood with 42 cancers, using multivariable Cox proportional hazards models in the European Prospective Investigation into Cancer and Nutrition cohort. Of 241 323 participants (31% men), 20% lost and 32% gained weight (>0.4 to 5.0 kg/year) during 6.9 years (average). During 8.0 years of follow-up after the second weight assessment, 20 960 incident cancers were ascertained. Independent of baseline BMI, weight gain (per one kg/year increment) was positively associated with cancer of the corpus uteri (hazard ratio HR = 1.14; 95% confidence interval: 1.05-1.23). Compared to stable weight (+/-0.4 kg/year), weight gain (>0.4 to 5.0 kg/year) was positively associated with cancers of the gallbladder and bile ducts (HR = 1.41; 1.01-1.96), post-menopausal breast (HR = 1.08, 1.00-1.16) and thyroid (HR = 1.40; 1.04-1.90). Compared to maintaining normal weight, maintaining overweight or obese BMI (World Health Organization categories) was positively associated with most obesity-related cancers. Compared to maintaining the baseline BMI category, weight gain to a higher BMI category was positively associated with cancers of the post-menopausal breast (HR = 1.19; 1.06-1.33), ovary (HR = 1.40; 1.04-1.91), corpus uteri (HR = 1.42; 1.06-1.91), kidney (HR = 1.80; 1.20-2.68) and pancreas in men (HR = 1.81; 1.11-2.95). Losing weight to a lower BMI category, however, was inversely associated with cancers of the corpus uteri (HR = 0.40; 0.23-0.69) and colon (HR = 0.69; 0.52-0.92). Our findings support avoiding weight gain and encouraging weight loss in middle adulthood.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|x 0
|f POF IV
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Pagoni, Panagiota
|b 1
700 1 _ |a Ferrari, Pietro
|0 0000-0001-9358-7338
|b 2
700 1 _ |a Cross, Amanda J
|b 3
700 1 _ |a Tzoulaki, Ioanna
|b 4
700 1 _ |a Muller, David C
|b 5
700 1 _ |a Weiderpass, Elisabete
|b 6
700 1 _ |a Freisling, Heinz
|b 7
700 1 _ |a Murphy, Neil
|0 0000-0003-3347-8249
|b 8
700 1 _ |a Dossus, Laure
|b 9
700 1 _ |a Fortner, Renee Turzanski
|0 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2
|b 10
|u dkfz
700 1 _ |a Agudo, Antonio
|b 11
700 1 _ |a Overvad, Kim
|b 12
700 1 _ |a Perez-Cornago, Aurora
|b 13
700 1 _ |a Key, Timothy J
|b 14
700 1 _ |a Brennan, Paul
|b 15
700 1 _ |a Johansson, Mattias
|b 16
700 1 _ |a Tjønneland, Anne
|b 17
700 1 _ |a Halkjaer, Jytte
|b 18
700 1 _ |a Boutron-Ruault, Marie-Christine
|0 0000-0002-5956-5693
|b 19
700 1 _ |a Artaud, Fanny
|b 20
700 1 _ |a Severi, Gianluca
|0 0000-0001-7157-419X
|b 21
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 22
|u dkfz
700 1 _ |a Schulze, Matthias B
|b 23
700 1 _ |a Bergmann, Manuela M
|b 24
700 1 _ |a Masala, Giovanna
|b 25
700 1 _ |a Grioni, Sara
|b 26
700 1 _ |a Simeon, Vittorio
|b 27
700 1 _ |a Tumino, Rosario
|b 28
700 1 _ |a Sacerdote, Carlotta
|0 0000-0002-8008-5096
|b 29
700 1 _ |a Skeie, Guri
|b 30
700 1 _ |a Rylander, Charlotta
|b 31
700 1 _ |a Borch, Kristin Benjaminsen
|b 32
700 1 _ |a Quirós, J Ramón
|b 33
700 1 _ |a Rodriguez-Barranco, Miguel
|b 34
700 1 _ |a Chirlaque, Maria-Dolores
|b 35
700 1 _ |a Ardanaz, Eva
|b 36
700 1 _ |a Amiano, Pilar
|b 37
700 1 _ |a Drake, Isabel
|0 0000-0002-6500-6310
|b 38
700 1 _ |a Stocks, Tanja
|b 39
700 1 _ |a Häggström, Christel
|0 0000-0001-6808-4405
|b 40
700 1 _ |a Harlid, Sophia
|b 41
700 1 _ |a Ellingjord-Dale, Merete
|b 42
700 1 _ |a Riboli, Elio
|b 43
700 1 _ |a Tsilidis, Konstantinos K
|b 44
773 _ _ |a 10.1002/ijc.33339
|g p. ijc.33339
|0 PERI:(DE-600)1474822-8
|n 7
|p 1637-1651
|t International journal of cancer
|v 148
|y 2021
|x 1097-0215
909 C O |o oai:inrepo02.dkfz.de:163961
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
913 0 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Cancer risk factors and prevention
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2021
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2020-02-26
|w ger
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2020-02-26
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-02-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-02-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
|d 2020-02-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-02-26
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
|d 2020-02-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-02-26
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
|d 2020-02-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-02-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2020-02-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2020-02-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2020-02-26
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J CANCER : 2018
|d 2020-02-26
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2020-02-26
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21